Menu

• Ask a Health Expert about CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
• Post Your Side Effect related to CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
• CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY and FDA Warnings
• CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY in Patients Wiki
• Report CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY in Drug Side Effect Survey

CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY side effect

What is CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Prograf Side Effects Report #5601376-X
Physician from UNITED STATES reported PROGRAF problem on Dec 21, 2007. Female patient, 44 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, csf protein increased, facial palsy, light chain analysis increased, . PROGRAF dosage: 3 MG, BID, ORAL; 1 MG, BID, ORAL. Patient recovered.

Prograf Side Effects Report #5601377-1
PROGRAF problem was reported by a Physician from UNITED STATES on Dec 21, 2007. Male patient, 53 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, . PROGRAF dosage: 12 MG, BID, ORAL; 7 MG, BID, ORAL; 2 MG, BID, ORAL. Patient recovered.

Duragesic Side Effects Report #5447286-2
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Aug 30, 2007. Female patient, weighting 190.0 lb, was diagnosed with pain, blood potassium decreased, systemic lupus erythematosus, fibromyalgia, swelling and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, nausea, osteoporosis, . DURAGESIC dosage: unknown. During the same period patient was treated with OXYCODONE AND ACETAMINOPHEN, PREDNISONE, ACIPHEX, CELLCEPT, ESTAZOLAM, FUROSEMIDE. Patient recovered.

Raptiva Side Effects Report #5728111-9
RAPTIVA problem was reported by a Health Professional from SWITZERLAND on Apr 30, 2008. Male patient was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, renal failure chronic, . RAPTIVA dosage: unknown. Patient was hospitalized. Patient recovered.


Janumet Side Effects Report #5743433-3
Pharmacist from UNITED STATES reported JANUMET problem on May 19, 2008. Male patient, 80 years of age, was diagnosed with diabetes mellitus and was treated with JANUMET. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, guillain-barre syndrome, . JANUMET dosage: unknown. Patient was hospitalized. Patient recovered.

Raptiva Side Effects Report #5709353-5
RAPTIVA problem was reported by a Health Professional from SWITZERLAND on Apr 11, 2008. Male patient was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, nephroangiosclerosis, . RAPTIVA dosage: unknown. Patient was hospitalized. Patient recovered.

Depocon Side Effects Report #5366594-7
Physician from AUSTRIA reported DEPOCON problem on June 13, 2007. Female patient, 27 years of age, was diagnosed with contraception and was treated with DEPOCON. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, cytomegalovirus infection, pulmonary embolism, . DEPOCON dosage: unknown. Patient recovered.

Raptiva Side Effects Report #5279681-9
RAPTIVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Male patient, 43 years of age, was diagnosed with psoriasis and was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: chronic inflammatory demyelinating polyradiculoneuropathy, injection site anaesthesia, . RAPTIVA dosage: 125 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with HUMALOG. Patient recovered.

Zetia Side Effects Report #5568585-X
Consumer or non-health professional from UNITED STATES reported ZETIA problem on Dec 13, 2007. Female patient, 74 years of age, was diagnosed with blood cholesterol and was treated with ZETIA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chronic inflammatory demyelinating polyradiculoneuropathy, colitis, diabetic neuropathy, gallbladder disorder, renal failure, rhabdomyolysis, . ZETIA dosage: unknown. During the same period patient was treated with PRILOSEC, LACTULOSE, NEOMYCIN, SYNTHROID, FUROSEMIDE, WELCHOL, EFFEXOR. Patient was hospitalized. Patient died on 03/02/2006.


Prograf Side Effects Report #5574538-8
PROGRAF problem was reported by a Physician from UNITED STATES on Dec 07, 2007. Male patient, 45 years of age, was diagnosed with immunosuppression and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: blood cholesterol decreased, chronic inflammatory demyelinating polyradiculoneuropathy, cytomegalovirus antibody positive, demyelinating polyneuropathy, diarrhoea, fatigue, headache, liver transplant rejection, . PROGRAF dosage: 7 MG, BID, ORAL; 5 MG, BID, ORAL; 4 MG, BID, ORAL; 3 MG, BID, ORAL. During the same period patient was treated with CORTICOSTEROID NOS. Patient recovered.

Remicade Side Effects Report #5446060-0
Consumer or non-health professional from UNITED STATES reported REMICADE problem on Aug 29, 2007. Male patient, weighting 190.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: arthritis, chronic inflammatory demyelinating polyradiculoneuropathy, . REMICADE dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.

Abatacept Side Effects Report #5749735-9
ABATACEPT problem was reported by a Physician from UNITED STATES on May 22, 2008. Male patient, 56 years of age, weighting 130.0 lb, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: asthenia, chronic inflammatory demyelinating polyradiculoneuropathy, guillain-barre syndrome, hepatitis c virus, liver disorder, lung infiltration, neuropathy peripheral, paraesthesia, therapeutic response decreased, . ABATACEPT dosage: 750 MG DAY 0, 15, Q 28 DA IV DRIP. Patient died on 05/07/2008.

Zavesca Side Effects Report #5319705-3
Physician from FRANCE reported ZAVESCA problem on Apr 20, 2007. Female patient, 17 years of age, weighting 106.9 lb, was diagnosed with gaucher's disease and was treated with ZAVESCA. After drug was administered, patient experienced the following problems/side effects: acquired claw toe, chronic inflammatory demyelinating polyradiculoneuropathy, condition aggravated, diarrhoea, epilepsy, flatulence, guillain-barre syndrome, joint sprain, . ZAVESCA dosage: 100 MG, TID, ORAL. During the same period patient was treated with LAMICTAL, TOPIRAMATE, CLONAZEPAM, KEPPRA. Patient was hospitalized. Patient recovered.

Actos Side Effects Report #5314650-1
ACTOS problem was reported by a Physician from JAPAN on Apr 16, 2007. Male patient, 54 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, chronic inflammatory demyelinating polyradiculoneuropathy, hypercholesterolaemia and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: cholangitis, chronic inflammatory demyelinating polyradiculoneuropathy, computerised tomogram abnormal, diabetes mellitus inadequate control, gastric disorder, glycosylated haemoglobin increased, hepatic cyst, hepatic necrosis, hepatocellular damage, . ACTOS dosage: unknown. During the same period patient was treated with IMURAN, LIPITOR, PREDNISOLONE, NOVORAPID. Patient was hospitalized. Patient recovered.


Pegasys Side Effects Report #5357070-6
Consumer or non-health professional from UNITED STATES reported PEGASYS problem on June 12, 2007. Female patient, 47 years of age, weighting 140.0 lb, was diagnosed with hepatitis c and was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, autoimmune thyroiditis, chronic inflammatory demyelinating polyradiculoneuropathy, fall, neuropathy peripheral, . PEGASYS dosage: 180MG/0.5ML WEEKLY SQ. During the same period patient was treated with COPEGUS. Patient recovered.